◆ 会议时间：2026年10月12-15日
◆ 会议地点：澳大利亚 悉尼

◆ 会议简介：

2026年第29届亚洲和大洋洲妇产科联合会(AOFOG)大会将于2026年10月12-15日在澳大利亚悉尼举行。

亚洲和大洋洲妇产科联合会（AOFOG）最初构想于1954年，将其作为国际妇产科联合会的亚洲分部，随后在1957年东京举行的成立会议上，决定设立亚洲妇产科联合会。1959年，澳大利亚和新西兰作为准会员加入联合会，1979年这两个国家被接纳为正式成员，名称改为亚洲和大洋洲妇产科联合会。AOCOG现前有28国家学会成员，其宗旨是宣促进产科、妇科和生殖生物学的科学和艺术； 促进女性终生的健康保健；促进宫内和新生儿健康；支持人口控制的研究和实施；促进国际合作与交流，特别是在亚洲和大洋洲地区。AOFOG每两年举办一次大会，以更新和分享关于妇女生殖健康方面的知识。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

Asia and Oceania Congress of Obstetrics and Gynaecology (AOFOG) Congress

Date:
12-15 October 2026

Venue:
Sydney | Australia

Theme：
Equivolution: Equity and Sustainability in Women's Health

Co-organized by：
Asia & Oceania Federation meuip of Obstetrics & Gynaecology (AOFOG)
Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG)

摘要征文投稿：

The deadline for abstract submission is 23:59 hours, AEST, Wednesday 1 April 2026.

点此提交摘要>>>Submit Abstract>>>

ABSTRACT TEMPLATE A

ABSTRACT TEMPLATE B

General submission guidelines
Outlined below are the general guidelines that must be followed.

• All abstracts must be submitted electronically via the online Abstract Submission Portal by the presenting author.
• Submission of several abstracts generated from the same study should be avoided.
• Abstracts must be submitted by the presenting author. All correspondence will be sent to the submitting author by email.
• Please note: changes of author are not permitted, with the exception of special circumstances, which will be considered by the Organising Committee.
• Only one author per abstract can be nominated as the ‘presenting author’.
• All submissions must be accompanied by a maximum 80-word biographical paragraph of the presenting author.
  • Biographical details should be written in full sentences (not dot points) and in third person.
  • Biographical details will be used by the session Chair for introductions purposes and may also be published in the AOFOG Congress literature/app.

Items required before submitting an abstract
Please ensure the following required information is available before beginning the online abstract submission process:

• Your contact details.
• The title of your abstract.
• Name and organisation of your co-author/s, if applicable.
• Your (the presenting author’s) biographical details. 
• Your abstract prepared in the correct format. 

What is an encore presentation?

• An encore presentation is one where you have already presented/published the submitted work before.
  • For example if you have presented the work at another women’s health event.

• Does the AOFOG Congress 2026 accept encore presentations?
  • No, encore presentations will not be accepted
  • If a study has been presented elsewhere before the AOFOG Congress 2026, it is not eligible for submission.

Abstract Content guidelines
Outlined below are the abstract content specific guidelines that must be followed.

• Length: The maximum of the main body of the abstract should be 250 words (i.e. excluding title, authors and institutions).
• Title: The abstract title should reflect the main content and nature of the abstract; do not use abbreviations within the title. The word limit on abstract titles is 25 words.
• Structure: Abstracts must be structured using the following format; any abstracts not following the correct structure may not be accepted.
  • Templates for these abstracts have been prepared to assist you and are available for download at the top of this page
  • Structure of abstracts: Original research / Systematic review / Audit
    • Introduction
    • Aims
    • Methods
    • Results
    • Discussion
    • Use submission template A

• • Structure of abstracts: Fascinoma/Case study / Literature review
    • Background
    • Aims
    • Case
    • Results
    • Discussion
    • Use submission template B

• Spelling and Grammar: All abstracts should be written in English and thoroughly checked for spelling and grammar before submission. Poor spelling and grammar will result in the abstract being marked down. Use standard abbreviations only; place any unusual abbreviations in brackets after the word appears for the first time within the body of the abstract, abbreviations may be used thereafter.

• Layout and Format

1. 1. Each abstract must be prepared in Microsoft Word (.doc, .docx). No other formats will be accepted. If you submit in another format, your abstract will be rejected.
   2. The title of the abstract should be written in title case.
   3. As abstracts are anonymously reviewed, please DO NOT include authors and affiliations in the abstract document itself. You can enter these details into the relevant fields within the online abstract submission portal.
   4. Please refrain from using printed enhancements such as italics, under lining, bold text etc. Italics may be used for non-English words or scientific names where necessary.
   5. Figures, tables, charts, and graphs are not permitted in the initial abstract submission.
   6. Please ensure results are detailed within the abstract (abstracts must not state ‘results will be presented at the meeting’) and appropriate statistical tests have been used and reported. Abstracts presented without results will not be accepted.
   7. Sources of funding should be indicated at the bottom of the abstract, as applicable.
   8. Use generic names of drugs, where applicable.
   9. References should be avoided or, if essential, should be kept to a minimum and presented in Vancouver (numbered) style. Note that all references will be included in the maximum abstract length (250 word total).
   10. Please note abstracts may be re-formatted and edited for publication in the program handbook.

• Changes to Final Abstract: Any necessary changes to your abstract must be made by the final submission date. Edits cannot be accepted after the submission deadline.

Abstracts can be submitted in the following areas of interest: 

• General Obstetrics
• General Gynaecology
• Gynaecological Oncology
• Reproductive Endocrinology and Infertility
• Urogynaecology
• Maternal Fetal Medicine
• Obstetrical and Gynaecological Ultrasound
• Women’s Mental Health and Wellbeing

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。